on a mobile?
vTap
    Loading...
 
 
Video
9270
Natco Pharma has cracked the technology to develop Teva's multiple sclerosis drug Copaxone, which has US sales of over USD 2 billion, reports CNBC-TV18. The drug is marketed by Sanofi Aventis. Natco ...
5 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Glatiramer acetate
Sanofi-Aventis
Pharmaceutical company
Teva Pharmaceutical Industries
CNBC-TV18
Multiple sclerosis
United States dollar
CNBC
Go to Feed to see what's new!
share
keep
 
 
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
 
 
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
 

Corporate Home Corporate Home News FAQ About Contact Forums Send Feedback
Privacy Policy and Terms of Use